153 related articles for article (PubMed ID: 37532968)
1. Crystal structures of main protease (M
Jiang H; Zou X; Zeng P; Zeng X; Zhou X; Wang J; Zhang J; Li J
Mol Biomed; 2023 Aug; 4(1):23. PubMed ID: 37532968
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants.
Jiang H; Zhou Y; Zou X; Hu X; Wang J; Zeng P; Li W; Zeng X; Zhang J; Li J
Biochemistry; 2023 Jul; 62(13):2055-2064. PubMed ID: 37222536
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of SARS-CoV-2 main protease (M
Jiang H; Zou X; Zhou X; Zhang J; Li J
Biochem Biophys Res Commun; 2024 Jan; 692():149352. PubMed ID: 38056159
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of main proteases of SARS-CoV-2 variants bound to a benzothiazole-based inhibitor.
Luo J; Wang W; Jiang H; Li W; Zeng P; Wang J; Zhou X; Zou X; Chen S; Wang Q; Zhang J; Li J
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1257-1264. PubMed ID: 37357528
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for the Inhibition of SARS-CoV-2 M
Zhao Z; Zhu Q; Zhou X; Li W; Yin X; Li J
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257765
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376.
Lin C; Zhu Z; Jiang H; Zou X; Zeng X; Wang J; Zeng P; Li W; Zhou X; Zhang J; Wang Q; Li J
J Mol Biol; 2024 Mar; 436(6):168474. PubMed ID: 38311236
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
Li J; Lin C; Zhou X; Zhong F; Zeng P; Yang Y; Zhang Y; Yu B; Fan X; McCormick PJ; Fu R; Fu Y; Jiang H; Zhang J
J Virol; 2022 Apr; 96(8):e0201321. PubMed ID: 35389231
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants.
Greasley SE; Noell S; Plotnikova O; Ferre R; Liu W; Bolanos B; Fennell K; Nicki J; Craig T; Zhu Y; Stewart AE; Steppan CM
J Biol Chem; 2022 Jun; 298(6):101972. PubMed ID: 35461811
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814.
Li J; Lin C; Zhou X; Zhong F; Zeng P; McCormick PJ; Jiang H; Zhang J
J Mol Biol; 2022 Aug; 434(16):167706. PubMed ID: 35809383
[TBL] [Abstract][Full Text] [Related]
10. Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally.
Kawashima S; Matsui Y; Adachi T; Morikawa Y; Inoue K; Takebayashi S; Nobori H; Rokushima M; Tachibana Y; Kato T
Biochem Biophys Res Commun; 2023 Feb; 645():132-136. PubMed ID: 36689809
[TBL] [Abstract][Full Text] [Related]
11. Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir.
Ullrich S; Ekanayake KB; Otting G; Nitsche C
Bioorg Med Chem Lett; 2022 Apr; 62():128629. PubMed ID: 35182772
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of SARS-CoV-2 antivirals characterizes 3CL
de Vries M; Mohamed AS; Prescott RA; Valero-Jimenez AM; Desvignes L; O'Connor R; Steppan C; Devlin JC; Ivanova E; Herrera A; Schinlever A; Loose P; Ruggles K; Koralov SB; Anderson AS; Binder J; Dittmann M
J Virol; 2021 Mar; 95(7):. PubMed ID: 33622961
[TBL] [Abstract][Full Text] [Related]
13. Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.
Zakharova MY; Kuznetsova AA; Uvarova VI; Fomina AD; Kozlovskaya LI; Kaliberda EN; Kurbatskaia IN; Smirnov IV; Bulygin AA; Knorre VD; Fedorova OS; Varnek A; Osolodkin DI; Ishmukhametov AA; Egorov AM; Gabibov AG; Kuznetsov NA
Front Pharmacol; 2021; 12():773198. PubMed ID: 34938188
[TBL] [Abstract][Full Text] [Related]
14. Theoretical insights into the binding interaction of Nirmatrelvir with SARS-CoV-2 Mpro mutants (C145A and C145S): MD simulations and binding free-energy calculation to understand drug resistance.
Purohit P; Panda M; Muya JT; Bandyopadhyay P; Meher BR
J Biomol Struct Dyn; 2023 Aug; ():1-20. PubMed ID: 37599474
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the inhibition of coronaviral main proteases by ensitrelvir.
Lin C; Jiang H; Li W; Zeng P; Zhou X; Zhang J; Li J
Structure; 2023 Sep; 31(9):1016-1024.e3. PubMed ID: 37421945
[TBL] [Abstract][Full Text] [Related]
16. Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 M
Ngo ST; Nguyen TH; Tung NT; Mai BK
RSC Adv; 2022 Jan; 12(6):3729-3737. PubMed ID: 35425393
[TBL] [Abstract][Full Text] [Related]
17. A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals.
Ma Y; Yang KS; Geng ZZ; Alugubelli YR; Shaabani N; Vatansever EC; Ma XR; Cho CC; Khatua K; Xiao J; Blankenship LR; Yu G; Sankaran B; Li P; Allen R; Ji H; Xu S; Liu WR
Eur J Med Chem; 2022 Oct; 240():114570. PubMed ID: 35779291
[TBL] [Abstract][Full Text] [Related]
18. Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor.
Hu X; Lin C; Xu Q; Zhou X; Zeng P; McCormick PJ; Jiang H; Li J; Zhang J
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146880
[TBL] [Abstract][Full Text] [Related]
19. The
Alugubelli YR; Geng ZZ; Yang KS; Shaabani N; Khatua K; Ma XR; Vatansever EC; Cho CC; Ma Y; Blankenship L; Yu G; Sankaran B; Li P; Allen R; Ji H; Xu S; Liu WR
bioRxiv; 2021 Dec; ():. PubMed ID: 34981058
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332.
Zhou Y; Wang W; Zeng P; Feng J; Li D; Jing Y; Zhang J; Yin X; Li J; Ye H; Wang Q
Biochem Biophys Res Commun; 2023 May; 657():16-23. PubMed ID: 36965419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
